USRE39821EExpiredUtility
Manufacture and expression of large structural genes
Est. expiryMay 6, 2002(expired)· nominal 20-yr term from priority
C12Q 1/68G01N 33/534A61P 31/12C07K 14/57Y10S930/142C07K 14/56A61P 43/00A61P 37/04C12N 15/70C07K 14/555C12P 21/02C12N 15/10Y10S435/811
63
PatentIndex Score
0
Cited by
134
References
3
Claims
Abstract
Illustrated is the preparation and expression of manufactured genes capable of directing synthesis of human immune and leukocyte interferons and of other biologically active proteinaceous products, which products differ from naturally-occurring forms in terms of the identity and/or relative position of one or more amino acids, and in terms of one or more biological and pharmacological properties but which substantially retain other such properties.
Claims
exact text as granted — not AI-modified1. [Met- −1 , des-Cys 1 , des-Tyr 2 , des-Cys 3 ] A Met −1 , des - Cys 1 , des - Tyr 2 , des - Cys 3 analog polypeptide of human IFN-γ polypeptide produced encoded by a DNA sequence coding therefor in a transformant organism, said polypeptide having substantially the characteristics of human immune interferon. transformed host cell.
2. A process for producing a Met −1 , des - Cys 1 , des - Tyr 2 , des - Cys 3 analog polypeptide of human IFN - N - γ comprising the steps of ( a ) growing a host cell transformed with a DNA sequence encoding the analog polypeptide, whereby said host cell expresses said DNA sequences, and ( b ) isolating the polypeptide produced by step ( a ) .
3. The process of claim 2 wherein the host cell is E. coli.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.